These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
238 related items for PubMed ID: 21262859
1. Alcohol Use Disorders Identification Test (AUDIT) scores are elevated in antipsychotic-induced hyperprolactinaemia. Lawford BR, Barnes M, Connor JP, Heslop K, Nyst P, Young RM. J Psychopharmacol; 2012 Feb; 26(2):324-9. PubMed ID: 21262859 [Abstract] [Full Text] [Related]
3. Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone. Segal M, Avital A, Derevenski A, Berstein S, Sandbank S, Weizman A. Int Clin Psychopharmacol; 2007 Jul; 22(4):192-6. PubMed ID: 17519641 [Abstract] [Full Text] [Related]
4. Prevalence of hyperprolactinaemia in a naturalistic cohort of schizophrenia and bipolar outpatients during treatment with typical and atypical antipsychotics. Bushe C, Shaw M. J Psychopharmacol; 2007 Sep; 21(7):768-73. PubMed ID: 17606473 [Abstract] [Full Text] [Related]
5. Relation between serum prolactin levels and antipsychotic response to risperidone in patients with schizophrenia. Charan A, Shewade DG, Rajkumar RP, Chandrasekaran A. Psychiatry Res; 2016 Jun 30; 240():209-213. PubMed ID: 27111215 [Abstract] [Full Text] [Related]
8. The effect of smoking status on the plasma concentration of prolactin already elevated by risperidone treatment in schizophrenia patients. Ohta C, Yasui-Furukori N, Furukori H, Tsuchimine S, Saito M, Nakagami T, Yoshizawa K, Kaneko S. Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar 30; 35(2):573-6. PubMed ID: 21216266 [Abstract] [Full Text] [Related]
9. Hyperprolactinemia and estimated dopamine D2 receptor occupancy in patients with schizophrenia: analysis of the CATIE data. Tsuboi T, Bies RR, Suzuki T, Mamo DC, Pollock BG, Graff-Guerrero A, Mimura M, Uchida H. Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug 01; 45():178-82. PubMed ID: 23727135 [Abstract] [Full Text] [Related]
14. Hyperprolactinaemia and antipsychotic therapy in schizophrenia. Hummer M, Huber J. Curr Med Res Opin; 2004 Aug 01; 20(2):189-97. PubMed ID: 15006013 [Abstract] [Full Text] [Related]
17. Relationship between prolactin levels and subjective endocrine-related adverse effects in patients with schizophrenia receiving long-term treatment with amisulpride. Kim EY, Kim SH, Lee NY, Jung DC, Kim YS, Ahn YM. Pharmacopsychiatry; 2012 Mar 01; 45(2):57-63. PubMed ID: 22411694 [Abstract] [Full Text] [Related]
18. Categorical prevalence and severity of hyperprolactinaemia in two UK cohorts of patients with severe mental illness during treatment with antipsychotics. Bushe C, Yeomans D, Floyd T, Smith SM. J Psychopharmacol; 2008 Mar 01; 22(2 Suppl):56-62. PubMed ID: 18477621 [Abstract] [Full Text] [Related]
19. A randomized, crossover comparison of herbal medicine and bromocriptine against risperidone-induced hyperprolactinemia in patients with schizophrenia. Yuan HN, Wang CY, Sze CW, Tong Y, Tan QR, Feng XJ, Liu RM, Zhang JZ, Zhang YB, Zhang ZJ. J Clin Psychopharmacol; 2008 Jun 01; 28(3):264-370. PubMed ID: 18480682 [Abstract] [Full Text] [Related]